Sequential patch testing in a patient treated with dupilumab then with upadacitinib: Differences in patch test results as well as in disease control

Contact Dermatitis. 2023 May;88(5):402-404. doi: 10.1111/cod.14278. Epub 2023 Jan 24.
No abstract available

Keywords: JAK inhibitor; allergic contact dermatitis; case report; dupilumab; patch test; upadacitinib.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Dermatitis, Allergic Contact* / diagnosis
  • Dermatitis, Allergic Contact* / etiology
  • Humans
  • Patch Tests

Substances

  • dupilumab
  • upadacitinib
  • Antibodies, Monoclonal, Humanized